Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript

ARRAY BIOPHARMA INC (ARRY) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/26/2021 GN Array Technologies Secures Contract for up to 4GW of Trackers
03/23/2021 GN Array Technologies, Inc. Announces Closing of Secondary Offering of 35,475,457 Shares
03/18/2021 GN Array Technologies, Inc. Announces Pricing of Secondary Offering of 31,054,971 Shares
03/16/2021 GN Array Technologies, Inc. Announces Launch of Secondary Offering of 31,054,971 Shares
03/09/2021 GN Array Technologies, Inc. Reports Financial Results for the Fourth Quarter and Full Year 2020
02/19/2021 GN Array Technologies, Inc. Announces Fourth Quarter & Full-Year 2020 Earnings Release Date and Conference Call
12/07/2020 GN Array Technologies, Inc. Announces Closing of Secondary Offering of 36,656,250 Shares
12/03/2020 GN Array Technologies, Inc. Announces Pricing of Upsized Secondary Offering of 31,875,000 Shares
11/30/2020 GN Array Technologies, Inc. Announces Launch of Secondary Offering of 25 Million Shares
11/30/2020 GN UPDATE -- Array Technologies announces a 1GW purchase agreement with RP Construction Services
11/10/2020 GN Lightsource bp announces a 1.4GW global purchase agreement with Array Technologies
10/30/2020 GN Array Technologies, Inc. Announces Third Quarter 2020 Earnings Release Date and Conference Call
10/19/2020 GN Array Technologies, Inc. Announces Closing of Initial Public Offering
10/14/2020 GN Array Technologies, Inc. Announces Pricing of Upsized Initial Public Offering
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/12/2019 SC 13G/A FMR LLC reports a 0.1% stake in ARRAY BIOPHARMA INC ?
08/09/2019 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
07/30/2019 4 VAN LUNSEN GIL J (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 24,297 shares @ $48, valued at $1.2M
Disposed/sold 5,000 shares @ $0
Disposed/sold 25,000 options to buy @ $10.47, valued at $261.8k
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 4 Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 259,891 shares @ $48, valued at $12.5M
Disposed/sold 442,190 shares @ $0
Disposed/sold 545,820 options to buy @ $3.61, valued at $2M
Disposed/sold 345,312 options to buy @ $4.63, valued at $1.6M
Disposed/sold 113,438 options to buy @ $7.3, valued at $828.1k
Disposed/sold 453,750 options to buy @ $3, valued at $1.4M
Disposed/sold 421,875 options to buy @ $8.79, valued at $3.7M
Disposed/sold 600,000 options to buy @ $10.92, valued at $6.6M
Disposed/sold 678,750 options to buy @ $15.97, valued at $10.8M
07/30/2019 4 Sharp Shalini (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 5,000 shares @ $48, valued at $240k
Disposed/sold 5,000 shares @ $0
Disposed/sold 25,000 options to buy @ $8.7, valued at $217.5k
Disposed/sold 25,000 options to buy @ $10.47, valued at $261.8k
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 4 Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 209,543 shares @ $48, valued at $10.1M
Disposed/sold 114,821 shares @ $0
Disposed/sold 87,500 options to buy @ $7.3, valued at $638.8k
Disposed/sold 187,500 options to buy @ $3, valued at $562.5k
Disposed/sold 270,828 options to buy @ $8.79, valued at $2.4M
Disposed/sold 289,500 options to buy @ $10.92, valued at $3.2M
Disposed/sold 289,500 options to buy @ $15.97, valued at $4.6M
07/30/2019 4 Saccomano Nicholas A (CSO) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 150,190 shares @ $48, valued at $7.2M
Disposed/sold 61,813 shares @ $0
Disposed/sold 165,000 options to buy @ $7.3, valued at $1.2M
Disposed/sold 82,500 options to buy @ $3, valued at $247.5k
Disposed/sold 131,250 options to buy @ $8.79, valued at $1.2M
Disposed/sold 168,000 options to buy @ $10.92, valued at $1.8M
Disposed/sold 138,000 options to buy @ $15.97, valued at $2.2M
07/30/2019 4 Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 71,022 shares @ $48, valued at $3.4M
Disposed/sold 130,542 shares @ $0
Disposed/sold 12,500 options to buy @ $8.2, valued at $102.5k
Disposed/sold 236,250 options to buy @ $7.3, valued at $1.7M
Disposed/sold 236,250 options to buy @ $3, valued at $708.8k
Disposed/sold 313,989 options to buy @ $8.79, valued at $2.8M
Disposed/sold 335,250 options to buy @ $10.92, valued at $3.7M
Disposed/sold 315,750 options to buy @ $15.97, valued at $5M
07/30/2019 4 Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 15,000 shares @ $48, valued at $720k
Disposed/sold 5,000 shares @ $0
Disposed/sold 20,000 options to buy @ $4.51, valued at $90.2k
Disposed/sold 25,000 options to buy @ $5.6, valued at $140k
Disposed/sold 25,000 options to buy @ $3.87, valued at $96.8k
Disposed/sold 25,000 options to buy @ $5.13, valued at $128.3k
Disposed/sold 25,000 options to buy @ $5.95, valued at $148.8k
Disposed/sold 25,000 options to buy @ $10.47, valued at $261.8k
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 4 LEFKOFF KYLE (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Unknown transaction of 22,635 shares @ $48, valued at $1.1M
Disposed/sold 85 shares @ $48, valued at $4.1k
Disposed/sold 5,000 shares @ $0
Unknown transaction of 20,000 shares @ $48, valued at $960k
Unknown transaction of 15,000 shares @ $48, valued at $720k
Disposed/sold 30,000 shares @ $48, valued at $1.4M
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 4 Haddock Jason (CFO) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 30,059 shares @ $48, valued at $1.4M
Disposed/sold 56,026 shares @ $0
Disposed/sold 404,450 options to buy @ $3.77, valued at $1.5M
Disposed/sold 105,302 options to buy @ $8.79, valued at $925.6k
Disposed/sold 168,000 options to buy @ $10.92, valued at $1.8M
Disposed/sold 157,500 options to buy @ $15.97, valued at $2.5M
07/30/2019 4 Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 15,000 shares @ $48, valued at $720k
Disposed/sold 5,000 shares @ $0
Disposed/sold 20,000 options to buy @ $2.6, valued at $52k
Disposed/sold 20,000 options to buy @ $4.36, valued at $87.2k
Disposed/sold 25,000 options to buy @ $5.6, valued at $140k
Disposed/sold 25,000 options to buy @ $3.87, valued at $96.8k
Disposed/sold 25,000 options to buy @ $5.13, valued at $128.3k
Disposed/sold 25,000 options to buy @ $5.95, valued at $148.8k
Disposed/sold 25,000 options to buy @ $10.47, valued at $261.8k
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 4 COX CARRIE SMITH (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Disposed/sold 8,000 shares @ $48, valued at $384k
Disposed/sold 10,000 shares @ $0
Disposed/sold 25,000 options to buy @ $14.93, valued at $373.3k
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 4 BAUM CHARLES M (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Unknown transaction of 15,000 shares @ $48, valued at $720k
Disposed/sold 5,000 shares @ $0
Disposed/sold 25,000 options to buy @ $10.47, valued at $261.8k
Disposed/sold 25,000 options to buy @ $14.55, valued at $363.8k
07/30/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/30/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/30/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/30/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/30/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy